Lambda Therapeutic Research Limited is a leading global Clinical Research Organization (CRO) headquartered in Ahmedabad. With experience in major disease areas, sound scientific and regulatory knowledge, our teams have a successful track record of conducting clinical trials across various therapeutic areas, with a major focus on Oncology.
Among all the types of breast cancer, Triple Negative Breast Cancer (TNBC) is one of the most challenging to treat. With an aim to develop a better therapy for patients with TNBC, Lambda has initiated a clinical trial at more than 40 sites across India.
A Subject of Concern
In India, breast cancer is the most frequently diagnosed cancer in women accounting for 27% of all cancer cases and 3 out of every 10 patients with breast cancer have Triple Negative Breast Cancer (TNBC).
We invite you to BE a HERO and support this trial by registering as an investigator or referring patients for this trial.